[1]
|
Siegel, R.L., Miller, K.D., Fuchs, H.E., et al. (2021) Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians, 71, 7-33. https://doi.org/10.3322/caac.21654
|
[2]
|
Lei, C., Zhao, B., Liu, L., et al. (2020) Expression and Clinical Significance of P62 Protein in Colon Cancer. Medicine (Baltimore), 99, E18791. https://doi.org/10.1097/MD.0000000000018791
|
[3]
|
De Rosa, M., Pace, U., Rega, D., et al. (2015) Genetics, Diagnosis and Management of Colorectal Cancer (Review). Oncology Reports, 34, 1087-1096. https://doi.org/10.3892/or.2015.4108
|
[4]
|
Koustas, E., Sarantis, P., Theoharis, S., et al. (2019) Autophagy-Related Proteins as a Prognostic Factor of Patients with Colorectal Cancer. American Journal of Clinical Oncology, 42, 767-776. https://doi.org/10.1097/COC.0000000000000592
|
[5]
|
Jeong, S.J., Zhang, X., Rodriguez-Velez, A., et al. (2019) p62/SQSTM1 and Selective Autophagy in Cardiometabolic Diseases. Antioxid Redox Signal, 31, 458-471. https://doi.org/10.1089/ars.2018.7649
|
[6]
|
Lamark, T., Svenning, S. and Johansen, T. (2017) Regulation of Selective Autophagy: The P62/SQSTM1 Paradigm. Essays in Biochemistry, 61, 609-624. https://doi.org/10.1042/EBC20170035
|
[7]
|
许焱, 祝成楼, 姬丹丹, 等. P62在消化系统肿瘤中的研究进展及展望[J]. 肿瘤预防与治疗, 2023, 36(12): 1047-1052.
|
[8]
|
Tao, M., Liu, T., You, Q., et al. (2020) P62 as a Therapeutic Target for Tumor. European Journal of Medicinal Chemistry, 193, Article ID: 112231. https://doi.org/10.1016/j.ejmech.2020.112231
|
[9]
|
Sanchez-Martin, P., Saito, T. and Komatsu, M. (2019) P62/SQSTM1: “Jack of All Trades” in Health and Cancer. The FEBS Journal, 286, 8-23. https://doi.org/10.1111/febs.14712
|
[10]
|
Kim, J.H. and Kim, I.W. (2020) P62 Manipulation Affects Chlorin E6-Mediated Photodynamic Therapy Efficacy in Colorectal Cancer Cell Lines. Oncology Letters, 19, 3907-3916. https://doi.org/10.3892/ol.2020.11522
|
[11]
|
Yan, X.Y., Zhong, X.R., Yu, S.H., et al. (2019) P62 Aggregates Mediated Caspase 8 Activation Is Responsible for Progression of Ovarian Cancer. Journal of Cellular and Molecular Medicine, 23, 4030-4042. https://doi.org/10.1111/jcmm.14288
|
[12]
|
Cai-McRae, X., Zhong, H. and Karantza, V. (2015) Sequestosome 1/P62 Facilitates HER2-Induced Mammary Tumorigenesis through Multiple Signaling Pathways. Oncogene, 34, 2968-2977. https://doi.org/10.1038/onc.2014.244
|
[13]
|
Lee, Y. and Weihl, C.C. (2017) Regulation of SQSTM1/P62 via UBA Domain Ubiquitination and Its Role in Disease. Autophagy, 13, 1615-1616. https://doi.org/10.1080/15548627.2017.1339845
|
[14]
|
Zhang, L.Z., Qi, W.H., Zhao, G., et al. (2019) Correlation between PTEN and P62 Gene Expression in Rat Colorectal Cancer Cell. Saudi Journal of Biological Sciences, 26, 1986-1990. https://doi.org/10.1016/j.sjbs.2019.08.006
|
[15]
|
Qi, J.L., He, J.R., Liu, C.B., et al. (2022) SQSTM1/P62 Regulate Breast Cancer Progression and Metastasis by Inducing Cell Cycle Arrest and Regulating Immune Cell Infiltration. Genes & Diseases, 9, 1332-1344. https://doi.org/10.1016/j.gendis.2021.03.008
|
[16]
|
Mathew, R., Karp, C.M., Beaudoin, B., et al. (2009) Autophagy Suppresses Tumorigenesis through Elimination of P62. Cell, 137, 1062-1075. https://doi.org/10.1016/j.cell.2009.03.048
|
[17]
|
张晨红, 章礼久, 宋莎莎. 结直肠癌组织中自噬相关蛋白Beclin1和P62的表达特点及意义[J]. 实用医学杂志, 2020, 36(2): 206-209.
|
[18]
|
Su, H., Yang, F., Fu, R., et al. (2022) Collagenolysis-Dependent DDR1 Signalling Dictates Pancreatic Cancer Outcome. Nature, 610, 366-372. https://doi.org/10.1038/s41586-022-05169-z
|
[19]
|
Bjorkoy, G., Lamark, T., Pankiv, S., et al. (2009) Monitoring Autophagic Degradation of p62/SQSTM1. Methods in Enzymology, 452, 181-197. https://doi.org/10.1016/S0076-6879(08)03612-4
|
[20]
|
Chao, X., Wang, S., Fulte, S., et al. (2022) Hepatocytic P62 Suppresses Ductular Reaction and Tumorigenesis in Mouse Livers with MTORC1 Activation and Defective Autophagy. Journal of Hepatology, 76, 639-651. https://doi.org/10.1016/j.jhep.2021.10.014
|
[21]
|
Vargas, J., Hamasaki, M., Kawabata, T., et al. (2023) The Mechanisms and Roles of Selective Autophagy in Mammals. Nature Reviews Molecular Cell Biology, 24, 167-185. https://doi.org/10.1038/s41580-022-00542-2
|
[22]
|
Shi, Q., Jin, X., Zhang, P., et al. (2022) SPOP Mutations Promote P62/SQSTM1-Dependent Autophagy and Nrf2 Activation in Prostate Cancer. Cell Death and Differentiation, 29, 1228-1239. https://doi.org/10.1038/s41418-021-00913-w
|
[23]
|
Xiang, X., Qin, H.G., You, X.M., et al. (2017) Expression of P62 in Hepatocellular Carcinoma Involving Hepatitis B Virus Infection and Aflatoxin B1 Exposure. Cancer Medicine, 6, 2357-2369. https://doi.org/10.1002/cam4.1176
|
[24]
|
Mizuno, Y., Shimada, S., Akiyama, Y., et al. (2018) DEPDC5 Deficiency Contributes to Resistance to Leucine Starvation via P62 Accumulation in Hepatocellular Carcinoma. Scientific Reports, 8, Article No. 106. https://doi.org/10.1038/s41598-017-18323-9
|
[25]
|
Liu, J.L., Chen, F.F., Lung, J., et al. (2014) Prognostic Significance of P62/SQSTM1 Subcellular Localization and LC3B in Oral Squamous Cell Carcinoma. British Journal of Cancer, 111, 944-954. https://doi.org/10.1038/bjc.2014.355
|
[26]
|
Burdelski, C., Reiswich, V., Hube-Magg, C., et al. (2015) Cytoplasmic Accumulation of Sequestosome 1 (P62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer. Clinical Cancer Research, 21, 3471-3479. https://doi.org/10.1158/1078-0432.CCR-14-0620
|
[27]
|
Niklaus, M., Adams, O., Berezowska, S., et al. (2017) Expression Analysis of LC3B and P62 Indicates Intact Activated Autophagy Is Associated with an Unfavorable Prognosis in Colon Cancer. Oncotarget, 8, 54604-54615. https://doi.org/10.18632/oncotarget.17554
|
[28]
|
Linares, J.F., Amanchy, R., Greis, K., et al. (2017) Correction for Linares et al., “Phosphorylation of p62 by cdk1 Controls the Timely Transit of Cells through Mitosis and Tumor Cell Proliferation”. Molecular and Cellular Biology, 37, e00252-17. https://doi.org/10.1128/MCB.00252-17
|
[29]
|
Yu, S., Wang, Y., Jing, L., et al. (2017) Autophagy in the “Inflammation-Carcinogenesis” Pathway of Liver and HCC Immunotherapy. Cancer Letters, 411, 82-89. https://doi.org/10.1016/j.canlet.2017.09.049
|
[30]
|
Dariya, B., Aliya, S., Merchant, N., et al. (2020) Colorectal Cancer Biology, Diagnosis, and Therapeutic Approaches. Critical Reviews™ in Oncogenesis, 25, 71-94. https://doi.org/10.1615/CritRevOncog.2020035067
|
[31]
|
Alsamman, K. and El-Masry, O.S. (2018) Staurosporine Alleviates Cisplatin Chemoresistance in Human Cancer Cell Models by Suppressing the Induction of SQSTM1/P62. Oncology Reports, 40, 2157-2162. https://doi.org/10.3892/or.2018.6615
|
[32]
|
李佳军, 李晓丽. 自噬相关蛋白Beclin1、P62在结直肠癌中的表达及临床意义[J]. 胃肠病学和肝病学杂志, 2022, 31(4): 463-466.
|
[33]
|
Ozaki, A., Motomura, H., Tamori, S., et al. (2022) High Expression of P62 and ALDH1A3 Is Associated with Poor Prognosis in Luminal B Breast Cancer. Anticancer Research, 42, 3299-3312. https://doi.org/10.21873/anticanres.15818
|
[34]
|
Lu, Y., Wang, Q., Zhou, Y., et al. (2018) Overexpression of P62 Is Associated with Poor Prognosis and Aggressive Phenotypes in Osteosarcoma. Oncology Letters, 15, 9889-9895. https://doi.org/10.3892/ol.2018.8579
|